Navigation Links
Breast Cancer Clinical Results Show Test Can Differentiate Normal, Early and Later Stage Cancers
Date:2/5/2009

TORONTO, Feb. 5 /PRNewswire-FirstCall/ - Predictive medicine company PreMD Inc. (TSX: PMD; PREMF.pk) today announced that its recently completed clinical trial data was presented at the 4th Annual Academic Surgical Congress in Fort Myers, FL. The peer reviewed data was presented by Dr. Anees B. Chagpar from the University of Louisville. The presentation entitled, "Quantitative Galactose Oxidase Schiff's reaction in Nipple Aspirate Fluid may distinguish women with or without Breast Cancer" concluded by stating that "GOS reactivity as measured by adjusted chroma values are significantly different between normal patients, those with Ductal Carcenoma In Situ and those with invasive cancer" and that "these results warrant further investigation".

"We are extremely pleased that the data was supportive of this novel breast cancer test and that the investigators feel that there is a need to continue to explore the potential of this test, and thus confirm that there is value to the technology. However, it is clear that funding to develop these potentially valuable tests is not readily available today and as such, work on this test will cease, at least for a while," said Dr. Brent Norton, President and CEO of PreMD Inc. "We are hopeful that one or more interested parties' steps forward to invest in or acquire this technology as it has the potential to advance the fight against this disease," he added.

About PreMD Inc.

PreMD Inc. is a leader in predictive medicine, dedicated to developing rapid, non-invasive tests for the early detection of life-threatening diseases. PreMD's cardiovascular products include PREVU* POC and PREVU* LT, both non-invasive skin cholesterol tests. The Company's cancer tests include ColorectAlertTM, LungAlertTM and a breast cancer test. PreMD's head office is located in Toronto, Ontario and its research and product development facility is at McMaster University in Hamilton, Ontario.
'/>"/>

SOURCE PreMD Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
6. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
7. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
8. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
9. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
10. Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research
11. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009).../ -- An urgent need for new medicines to treat neg... has prompted a growing number of collaborations a...lopment partnerships (PDPs), and pharmaceutical an...posium at the 58th annual meeting of the American ...these collaborations are opening up new avenues of...
(Date:11/20/2009)...re-FirstCall/ -- Unilens Vision Inc. (OTC Bulletin...evelops, licenses, manufactures, distributes and m...s operating results for the first quarter ended Se...ng royalty income, were $1,683,673 in the FY2010 f...n the previous year first quarter (FY2009). The d...
(Date:11/20/2009)...swire-FirstCall/ -- Landauer, Inc. ( LDR) , w...h quarter and full year of 2009 pre-market on Tues... a conference call for investors on Tuesday, Decem...may access the live call by dialing 877-941-9205 (...835 (international callers), or by visiting the "I...
Breaking Medicine Technology:ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 2ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 4Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Fenwal to Host Webinar on the Safety of 2 Unit Red Cell Collections From Young Donors 49825 1Fenwal to Host Webinar on the Safety of 2 Unit Red Cell Collections From Young Donors 49825 2Fenwal to Host Webinar on the Safety of 2 Unit Red Cell Collections From Young Donors 49825 3New Therapy Found to Prevent Heart Failure 4636 1New Therapy Found to Prevent Heart Failure 4636 2Being overweight obese during early adulthood associated with greater risk of pancreatic cancer 49818 1Being overweight obese during early adulthood associated with greater risk of pancreatic cancer 49818 2Being overweight obese during early adulthood associated with greater risk of pancreatic cancer 49818 3
...illion over Five Years, WASHINGTON and FRANKLIN L...y Plan for AIDS Relief (Emergency Plan/PEPFAR),joi... the signing of a,Memorandum of Understanding toda...rove overall laboratory systems and services in Af...tuberculosis (TB). PEPFAR is the largest internat...
...ax, Inc.,announced today that it has concluded a p...uenza vaccine based on its proprietary replicon ve...assess the properties of this,unique vector system...influenza vaccines. The study was a placebo-contr...dults, 18-40 years old, which evaluated the safety...
Other Medicine Technology:BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB 2BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB 3BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB 4AlphaVax Announces Results From Phase 1 Influenza Vaccine Clinical Trial 2
(Date:11/22/2009)...aw Firm’s attorneys are offering a free XOLA...ay have experienced heart attack, stroke or other ... St. Louis, MO (Vocus) Novemb...neys offering free XOLAIR case review for serious... The attorneys of the Onder Law Firm include exper...
(Date:11/22/2009)...attack recipient,s tissue, study finds, , ...rs are reporting that a genetic variation -- a mis...d a bone-marrow transplant will develop a complica...mmune system-related complication occurs after sur...donor does not. , When that,s the case, the im...
(Date:11/22/2009)...wire-USNewswire/ -- Congressman Chaka Fattah (D-PA...tates Senate,s vote tonight to proceed to debate o...ors Arlen Specter and Bob Casey deserve the thanks...ing stand-up, critical votes in the Senate tonight...ealth Care Reform legislation to full debate. The ...
(Date:11/21/2009)...ewswire-USNewswire/ -- A regional initiative launc...r blindness) in the Americas has substantially red..., as evidenced by a 31% decrease in the number of ...six endemic countries. Results were reported toda...ty of Tropical Medicine and Hygiene (ASTMH). ,...
(Date:11/21/2009)...,s most popular and addictive game, SplitWords, is... Mountain View, CA (PRWEB) No...addictive game, SplitWords, is now available on th...o help banish that ,tip of the tongue, syndrome fo...llenges the brain by encouraging users to form com...
Breaking Medicine News(10 mins):Health News:The Attorneys of The Onder Law Firm Offers Free XOLAIR Case Review 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3
...BURG, Pa., Jan. 5 Governor Edward G. Rendell expr... his administration -- now in their waning days --...mise patient care and limit a woman,s access to me..., rule that could have serious, detrimental impact...
... Entire Health Care System More Effective , , WAS...can manage their health and avoid hospitalization ...ment of Veterans Affairs (VA) in their homes, acco...nd is easy to use," said Secretary of Veterans Aff...
...X, Jan. 5 Senior Care Action Network (SCAN(R)) He...Plan, recently partnered with Dependable Medical T...0 seasoned van drivers about what it feels like to...wareness and skills in the community in dealing wi...
...X, Ariz., Jan. 5 VAS Communications, a multi-medi...by Dr. Edward B. Diethrich, Founder and Medical Di...t Hospital, has recently custom built a High-Defin... the honor of working along side of pioneering hea...
... Babies born to HIV-positive mothers and given th... six weeks of life to prevent infection via breast...stant HIV if they get infected anyway, a team of r...east-fed infants. , In a study led by res...
...,s ignition gadget prevents calls or texting while...s) -- A car key that prevents teens from talking o...been developed by University of Utah researchers. ...h or RFID (radio-frequency identification) technol...
Other Medicine News:Health News:Gov. Rendell Expresses Disappointment with Bush Administration's Last-Minute Regulation Limiting Patient Care 2Health News:Gov. Rendell Expresses Disappointment with Bush Administration's Last-Minute Regulation Limiting Patient Care 3Health News:VA Data Show Home Health Technology Improves Access to Care 2Health News:SCAN Health Plan Arizona Helps Drivers Understand the Challenges of Aging 2Health News:SCAN Health Plan Arizona Helps Drivers Understand the Challenges of Aging 3Health News:MD Goes HD: Phoenix Doctor Is First to Use New High-Definition Television Production Vehicle to Help Educate and Teach From the Operating Room. 2Health News:MD Goes HD: Phoenix Doctor Is First to Use New High-Definition Television Production Vehicle to Help Educate and Teach From the Operating Room. 3Health News:Prolonged nevirapine in breast-fed babies prevents HIV infection but leads to drug-resistant HIV 2Health News:Prolonged nevirapine in breast-fed babies prevents HIV infection but leads to drug-resistant HIV 3Health News:Car Key Device Jams Teens' Cell Phones 2
2005 Edition of Geriatrics At Your Fingertips (PDA Version)
...ultant, PDA Edition is designed for all physicians...imaging studies. It provides speedy access via you...ll help to determine whether imaging examinations ...s will generate the most information. The content ...
KR-8800 Auto Kerato-Refractometer
Medical Student's PDA Reference
Medicine Products: